Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Future Market

Six Predictions for an Industry in Transformation

Welltok and Oliver Wyman discuss why this year is healthcare's watershed moment and what may unfold in 2021.

Chairman of the Board, Welltok
Partner, Health and Life Sciences, Oliver Wyman

New Predictions on COVID-19 Vaccines and Herd Immunity

How COVID-19 case counts and vaccines may get us back to normalcy by June.

Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner and CMO, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

New Oliver Wyman analysis on when and how a vaccine may be available and key considerations for how to reach herd immunity.

CEO, Independent Grocers Alliance
Partner, Health and Life Sciences, Oliver Wyman

Predictions on the modernization and ultimately transformation of care in the home.

Senior Vice President, Highmark Health
Partner, Health and Life Sciences, Oliver Wyman

No matter the outcome of the election, here are your no-regret moves.

Insights in your inbox

Subscribe

How extended periods of suppressed utilization and a regulatory pause on record collection may influence plans' anticipated results next year.

Principal, Health and Life Sciences, Organizational Effectiveness, Oliver Wyman
Senior Advisor, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

The current supply of inpatient beds is far higher than what we need now, or even what we'll need a decade from now.

Principal, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Oliver Wyman Actuarial Consulting

Success awaits innovators that leverage pharma in a newly digitized world.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Even with drastically increased investment and adoption, we're still early in telemedicine’s trajectory.

Founder and CEO, Virta Health

To what extent is COVID-19 a catalyst for sustained employer change? And what should stakeholders be focused on next?

President and CEO, Business Group on Health
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe